Multi Medika Internasional Stock Earnings Per Share
| MMIX Stock | 75.00 1.00 1.32% |
Multi Medika Internasional fundamentals help investors to digest information that contributes to Multi Medika's financial success or failures. It also enables traders to predict the movement of Multi Stock. The fundamental analysis module provides a way to measure Multi Medika's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Multi Medika stock.
Multi |
Multi Medika Internasional Company Earnings Per Share Analysis
Multi Medika's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Multi Medika Internasional has an Earnings Per Share of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Pharmaceutical Retailers (which currently averages 0.0) industry. The earnings per share for all Indonesia stocks is 100.0% higher than that of the company.
Multi Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Multi Medika's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Multi Medika could also be used in its relative valuation, which is a method of valuing Multi Medika by comparing valuation metrics of similar companies.Multi Medika is currently under evaluation in earnings per share category among its peers.
Multi Fundamentals
| Return On Equity | 1.81 | |||
| Return On Asset | 0.37 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.18 % | |||
| Shares Owned By Insiders | 7.00 % | |||
| Price To Sales | 3.41 X | |||
| Revenue | 181.84 B | |||
| Gross Profit | 67.57 B | |||
| EBITDA | 33.57 B | |||
| Book Value Per Share | 27.86 X | |||
| Number Of Employees | 63 | |||
| Market Capitalization | 1.27 T |
About Multi Medika Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Multi Medika Internasional's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Multi Medika using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Multi Medika Internasional based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Multi Stock
Multi Medika financial ratios help investors to determine whether Multi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Multi with respect to the benefits of owning Multi Medika security.